Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Akerman

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Headache and Pain|March 15, 2018
PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchymaJames A Waschek, Serapio M Baca, Simon Akerman
British Journal of Pharmacology|July 9, 2004
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the catRobin James Storer, Simon Akerman, Peter J Goadsby
Neurobiology of Pain (Cambridge, Mass.)|March 28, 2023
Nitroglycerin as a model of migraine: Clinical and preclinical reviewPaula Sureda-Gibert, Marcela Romero-Reyes, Simon Akerman
Brain Research|July 29, 2008
Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockadeSimon Akerman, Philip R Holland, Peter J Goadsby
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2009
Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complexAnnabelle R Charbit, Simon Akerman, Peter J Goadsby
The Journal of Pharmacology and Experimental Therapeutics|October 5, 2006
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neuronsSimon Akerman, Philip R Holland, Peter J Goadsby
Current Opinion in Neurology|February 19, 2010
Dopamine: what's new in migraine?Annabelle R Charbit, Simon Akerman, Peter J Goadsby
Cephalalgia : an International Journal of Headache|September 12, 2025
Optimising combined treatment for migraine and temporomandibular disorders (TMDs)Marcela Romero-Reyes, Simon Akerman, Alan M Rapoport
Pharmacology & Therapeutics|December 7, 2016
Current and novel insights into the neurophysiology of migraine and its implications for therapeuticsSimon Akerman, Marcela Romero-Reyes, Philip R Holland
British Journal of Pharmacology|September 14, 2023
PACAP-38 related modulation of the cranial parasympathetic projection: A novel mechanism and therapeutic target in severe primary headacheSimon Akerman, Peter J Goadsby, Marcela Romero-Reyes
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Headache and Pain|March 15, 2018
PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchymaJames A Waschek, Serapio M Baca, Simon Akerman
British Journal of Pharmacology|July 9, 2004
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the catRobin James Storer, Simon Akerman, Peter J Goadsby
Neurobiology of Pain (Cambridge, Mass.)|March 28, 2023
Nitroglycerin as a model of migraine: Clinical and preclinical reviewPaula Sureda-Gibert, Marcela Romero-Reyes, Simon Akerman
Brain Research|July 29, 2008
Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockadeSimon Akerman, Philip R Holland, Peter J Goadsby
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2009
Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complexAnnabelle R Charbit, Simon Akerman, Peter J Goadsby
The Journal of Pharmacology and Experimental Therapeutics|October 5, 2006
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neuronsSimon Akerman, Philip R Holland, Peter J Goadsby
Current Opinion in Neurology|February 19, 2010
Dopamine: what's new in migraine?Annabelle R Charbit, Simon Akerman, Peter J Goadsby
Cephalalgia : an International Journal of Headache|September 12, 2025
Optimising combined treatment for migraine and temporomandibular disorders (TMDs)Marcela Romero-Reyes, Simon Akerman, Alan M Rapoport
Pharmacology & Therapeutics|December 7, 2016
Current and novel insights into the neurophysiology of migraine and its implications for therapeuticsSimon Akerman, Marcela Romero-Reyes, Philip R Holland
British Journal of Pharmacology|September 14, 2023
PACAP-38 related modulation of the cranial parasympathetic projection: A novel mechanism and therapeutic target in severe primary headacheSimon Akerman, Peter J Goadsby, Marcela Romero-Reyes
Pageof 8